June 9th 2021, 9:00pm
Introducing integrated palliative care to patients with a certain type of leukemia was shown to facilitate active coping strategies, which could improve a patient’s quality of life.
May 24th 2021, 9:00pm
Scientists have identified a potentially valuable genetic target in children with acute myeloid leukemia that could lead to further studies in immunotherapy drugs for the disease.
May 12th 2021, 1:00pm
An analysis of more than 3.5 million children born between January 1996 and December 2016 demonstrated a stronger association between Down syndrome and acute myeloid leukemia risk than has been previously reported.
May 11th 2021, 6:00pm
Treatment with a novel therapy as a single agent, or in combination with Venclexta, demonstrated a manageable safety profile and antileukemic effects in patients with relapsed/refractory acute myeloid leukemia. The study authors, however, note that more research is needed.
May 6th 2021, 9:00pm
Compared to a hypomethylating agent alone, combining the agent with Venclexta improved complete remission rates in patients with blast-phase myeloproliferative neoplasm.
April 27th 2021, 9:00pm
Patients with blood cancers are at a much higher risk of complications if they contract COVID-19, says an expert from the Leukemia & Lymphoma Society (LLS).
April 21st 2021, 6:00pm
Patients with acute myeloid leukemia experience post-traumatic stress disorder symptoms including intrusion, avoidance and hypervigilance one month after diagnosis.
March 31st 2021, 12:30am
The agency granted approval to the revised label of Vyxeos to now include treatment for newly diagnosed therapy-related acute myeloid leukemia or disease with myelodysplasia-related changes in pediatric patients aged 1 and older.
February 11th 2021, 4:00pm
This week on the “CURE Talks Cancer” podcast, we spoke with Nicole Schulz, who was diagnosed with acute myeloid leukemia at the age of 14, about how her life changed as a result of her treatment and why she now lives life to the fullest.
February 2nd 2021, 10:00pm
Onureg, an oral form of the chemotherapy azacitidine, in older patients with acute myeloid leukemia who were in remission after chemotherapy contributed to longer survival outcomes, compared to placebo.
Adding Darzalex to Standard of Care May Improve Survival in Newly Diagnosed Multiple Myeloma
A ‘Turning Point’ for Metastatic NSCLC Treatment
My Daughter, the Learning Opportunity
Expert Breaks Down Misconceptions About COVID-19 Vaccine
